Friday, January 12, 2018 10:15 PM ET
Significant Insider purchase Extends the buy Trend of Last 90 Days in Shares of Acer Therapeutics (ACER)
One Acer Therapeutics insider — Life Science Ventures Vi Gmbh & Co Kg Tvm, 10% Owner and Director — today, bought 333,333 shares having a market value of approximately $3,999,996, as revealed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 2,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 335,333 shares and have averaged 167,667 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Acer Therapeutics is greater than its 280-company peer group average. The Bio Therapeutic Drugs peer group saw 336 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Acer Therapeutics insiders is lower than its peers. Within the peer group there were 46,184,815 shares purchased and 40,770,209 shares sold with company insiders acquiring 24,724 shares on average over this time period.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to create and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.